Clinicians should engage in shared decision-making discussions with patients, explaining that while there is no official link between tirzepatide and worsening Graves disease, limited specific data exists regarding this patient population
Karla works with eligible patients exploring wellness-focused peptide programs, including GLOW Blend, BPC-157, TB-500, GHK-Cu, Sermorelin, Tesamorelin, Ipamorelin, CJC-1295, KLOW, Wolverine Blend, NAD+ therapy, and physician-guided medical weight loss programs
The duration mismatch is the whole story
This is where fitness professionals will play a pivotal role
While these individual cases have not yet consolidated into a class action, the growing number of claims could potentially lead to a class action in the future if a pattern of harm and insufficient warning is established across multiple cases